TY  - GEN
AU  - Varkaris,Andreas
AU  - Corn,Paul G
AU  - Parikh,Nila U
AU  - Efstathiou,Eleni
AU  - Song,Jian H
AU  - Lee,Yu-Chen
AU  - Aparicio,Ana
AU  - Hoang,Anh G
AU  - Gaur,Sanchaika
AU  - Thorpe,Lynnelle
AU  - Maity,Sankar N
AU  - Bar Eli,Menashe
AU  - Czerniak,Bogdan A
AU  - Shao,Yiping
AU  - Alauddin,Mian
AU  - Lin,Sue-Hwa
AU  - Logothetis,Christopher J
AU  - Gallick,Gary E
TI  - Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer
SN  - 1557-3265
PY  - 2016///1013
KW  - Anilides
KW  - pharmacology
KW  - Animals
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - drug effects
KW  - Bone Neoplasms
KW  - diagnosis
KW  - Cell Line, Tumor
KW  - Clinical Trials, Phase II as Topic
KW  - Disease Models, Animal
KW  - Drug Resistance, Neoplasm
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Male
KW  - Mice
KW  - Multicenter Studies as Topic
KW  - Neoplasm Staging
KW  - Phosphorylation
KW  - Positron-Emission Tomography
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-met
KW  - antagonists & inhibitors
KW  - Pyridines
KW  - Receptor, Fibroblast Growth Factor, Type 1
KW  - metabolism
KW  - Signal Transduction
KW  - Treatment Outcome
KW  - Tumor Burden
KW  - Vascular Endothelial Growth Factor Receptor-2
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-15-0235
ER  -